BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27588135)

  • 1. Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report.
    De Santis E; Masi S; Cordone I; Pisani F; Zuppi C; Mattei F; Conti L; Cigliana G
    Oncol Lett; 2016 Sep; 12(3):1884-1888. PubMed ID: 27588135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
    Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
    Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
    Dogaru M; Lazăr V; Coriu D
    Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma.
    Sharma A; Binazir T; Sintow A; Lee CC; Shaharyar S; Tache J
    Cureus; 2017 Jun; 9(6):e1400. PubMed ID: 28845377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin D-λ/λ biclonal multiple myeloma: A case report.
    He QL; Meng SS; Yang JN; Wang HC; Li YM; Li YX; Lin XH
    World J Clin Cases; 2021 Apr; 9(11):2576-2583. PubMed ID: 33889623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-secreting multiple myeloma switches to IgD of lamda type: a case report and review of literature.
    Gao L; Li Q; Kang J; Li C; Zhou J
    Int J Clin Exp Med; 2015; 8(9):16984-90. PubMed ID: 26629254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin D Multiple Myeloma With Rapidly Progressing Renal Failure.
    Modi J; Kamal J; Eter A; El-Sayegh S; El-Charabaty E
    J Clin Med Res; 2015 Aug; 7(8):653-5. PubMed ID: 26124916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous enzymatic cleavage of IgD myeloma protein giving a pattern of delta heavy chain disease.
    Rabhi H; Ghaffor M; Abbadi MC
    Arch Inst Pasteur Alger; 1989; 57():135-40. PubMed ID: 2518742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light chain types of IgD in human bone marrow and serum.
    van Nieuwkoop JA; Radl J
    Clin Exp Immunol; 1985 Jun; 60(3):654-60. PubMed ID: 3926359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
    Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
    Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of Serum Light Chain in Diagnosis and Evaluation of Efficacy for Multiple Myeloma].
    Yu Y; Teng XJ; Luo GL; Wu LX; Guo BQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):886-893. PubMed ID: 32552953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual myelomas: a review of IgD and IgE variants.
    Pandey S; Kyle RA
    Oncology (Williston Park); 2013 Aug; 27(8):798-803. PubMed ID: 24133829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Polymerized Kappa Light Chain Multiple Myeloma.
    Biaz A; Fataki CM; Bagadema DCS; Lazreq F; Machtani-Idrissi SE; Kabbaj DE; Dami A; Bouhsain S
    Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
    Caldini A; Nozzoli C; Terreni A; Staderini M; Berardi M; Biagioli T; Brogi M; Bosi A
    Clin Chem Lab Med; 2016 Jun; 54(6):991-5. PubMed ID: 26581069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
    Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
    Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgD/lambda plasmocytoma with immunoglobulin kappa light-chain genes in the germ-line configuration.
    Hauke G; Epplen JT; Chluba J; Hollmann A; Peter HH
    J Clin Immunol; 1988 Sep; 8(5):407-13. PubMed ID: 3141452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgD myeloma. Report of a case with unusual clinical and immunologic features.
    Valenzuela R; Govindarajan S; Tubbs R; Deodhar S; Bukowski R
    Am J Clin Pathol; 1979 Aug; 72(2):246-50. PubMed ID: 112852
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.